Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Typically disregarded brain lesions may warn of heightened stroke risk

  • Nanomedicine in the fight against thrombotic diseases

  • Increased risk of complications, death during delivery for women with epilepsy

  • Cognitive behavioral therapy for insomnia with psychiatric, medical conditions

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Restraint, confinement still an everyday practice in mental health settings

  • Age-related cognitive decline tied to immune-system molecule

  • New study again shows: More strokes with intracranial stents

  • People over 65 with traumatic brain injuries hospitalized four times as often as younger people

  • Uncovering the mechanism of our oldest anesthetic

  •